Stellar Biotechnologies Inc. (SBOTF)

[floored]

Actually the Rodman presentation only revealed one issue to me. Frank mentioned several times that the "stable" price of the GMP level klh would be discounted after the successful commercial launch of the clinical drugs Stellars clients are working on. I realize that Stellar is probably giving away the klh to open doors but when the time arrives for a sustainable, traceable supply is needed, they should charge a premium and not discount based on volume. Stellar has a 10 year jump on the next aquaculture facility that will come to be so they should capitalize on their monopoly while the capitalizing is available.